1 Day Virtual Drug Safety & Pharmacovigilance Regulatory Requirements Training Course: Learn Product Safety Regulatory Requirements for the US and EU

News provided by

Nov 17, 2023, 22:00 ET

DUBLIN, Nov. 17, 2023 /PRNewswire/ -- The "Global Regulatory Requirements for Drug Safety & Pharmacovigilance" training has been added to ResearchAndMarkets.com's offering.

This training course is designed to give pharmaceutical and biologic companies operating in the US and EU an introduction to product safety regulatory requirements. The course will illustrate the decision-making process and reasoning needed behind when and how to properly report incidents to regulatory authorities.

Product safety makes headlines every day - and the impact on a company's image, consumer confidence, and Wall Street's opinion is profound. Are you confident your current pharmacovigilance operations will meet the latest US, EU and UK expectations for compliance and keep your products on the market? Do you understand the processes needed to perform adequate risk assessment?

Not knowing which systems and processes you must have in place for your own safety reporting could mean you miss an important issue with significant consequences for your product. You must be sure you have the understanding you need to avoid product recall, are able to work to international standards and have implemented regulatory requirements for signaling and risk management.

What You'll Learn

An understanding of regulatory requirements for drug safety
Overview of US, EU and UK regulatory framework, including details of EU GVP modules and additional requirements for the UK
Contents of the PV System Master File (PSMF)
Requirements for quality oversight of drug safety
Regulations for signal management
EU and UK QPPV requirements and responsibilities
An engaging and experienced instructor
Multiple choice quizzes to test your understanding of the course

3.0 RAC CREDITS

RAPS - This course has been pre-approved by RAPS as eligible for up to 3.0 credits towards a participant's RAC recertification upon full completion.

Who Should Attend:

Almost everyone involved in drug development and marketing needs to know the basics of worldwide regulations regarding drug safety.

Staff who will benefit include:

Drug safety and pharmacovigilance
Regulatory affairs
Clinical development
Executives (including C-Level) with any legal responsibility for drug safety

Key Topics Covered:

Global Regulatory Requirements

Legalities - US
Legalities - EU
Penalties for Non-Compliance
Matrix of Safety Regulations
FDA Regulations
FDA Regulation for IND safety reporting
IND Annual Report
Literature Reporting
International Conference on Harmonisation (ICH)
ICH Topic Codes and Reports
CIOMS
Canadian Regulations
Key EU Components
EU Member States
What is Europe? EU, EEA, EFTA
Eudravigilance - Pre-Marketing Requirements
Eudravigilance - Post-Marketing Requirements
EUDRACT
EU Clinical Trial Directive
EU Clinical Trials Regulation
CTIS
Qualified Person for Pharmacovigilance (QPPV) requirements
Development Safety Update Report
European Signaling Regulations

EU Pharmacovigilance Legislation

Summary of Requirements
Penalties and fees
GVP modules
Quality systems
Audit and inspection
PV System Master File (PSMF)

ADR reporting

EU and ex-EU Requirements
Internet and Social Media
Post-Authorisation Studies
Biologics

Periodic Safety Update Reports

Periodic Benefit-Risk Evaluation Report
PSUR Periodicity, ex-EU
PSUR Periodicity, EU
PSUR (PBRER) New Features
PSUR Sections: Detailed Requirements

Signal management

MAH Responsibilities
Signal Detection
Signal Validation
EudraVigilance Monitoring
EudraVigilance Pilot Program

UK Regulatory Requirements

UK QPPV

Quiz Questions

Speakers:

Steve Jolley
DIA

Steve Jolley is a subject matter expert in all areas of global safety compliance and signal detection.

Steve has 37 years' experience in drug safety & pharmacovigilance and has worked with 300 clients in North America, Europe, Japan, India, China, the Middle East, and Africa. He holds degrees in mathematics and computer science from Cambridge University, England. He is an Adjunct Professor at Rutgers University and developed part of their Master's degree in Drug Safety and Pharmacovigilance.

Steve is a featured speaker with FDA, EMA and MHRA at conferences and webinars on auditing, signalling and data mining. He is a member of DIA's training faculty and is an instructor for DIA's Clinical Safety and Pharmacovigilance Certificate Program. In 2010 Steve was elected as chairman of the DIA's Clinical Safety and Pharmacovigilance steering committee for North America.

For more information about this training visit https://www.researchandmarkets.com/r/r109io

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets